市場調査レポート
商品コード
1525357

がん診断薬の世界市場 2024-2028

Global Cancer Diagnostics Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 170 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
がん診断薬の世界市場 2024-2028
出版日: 2024年07月12日
発行: TechNavio
ページ情報: 英文 170 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん診断薬市場は2023-2028年に177億4,450万米ドル、予測期間中のCAGRは13.64%で成長すると予測されます。

当レポートでは、がん診断薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がんの高い有病率、個別化医薬品の需要、創薬および市場開発におけるコスト削減の必要性によって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 11.73%
CAGR 13.64%
増分額 177億4,450万米ドル

本調査では、今後数年間のがん診断薬市場成長を牽引する主な要因として、研究開発の増加と技術の進歩を挙げています。また、ライセンス契約や製品の商品化など様々な戦略の採用や、人口が多い新興国に注力してプレゼンスを拡大するベンダーも、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • がん診断薬の世界市場 2018-2022
  • エンドユーザー別セグメント分析 2018-2022
  • タイプ別セグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション
  • 比較:エンドユーザー別
  • 病院と診療所:市場規模と予測 2023-2028
  • 診断検査室:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:タイプ別

  • 市場セグメンテーション
  • 比較:タイプ別
  • 体外診断:市場規模と予測 2023-2028
  • 画像診断:市場規模と予測 2023-2028
  • LDT:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア太平洋:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • フランス:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • General Electric Co.
  • GlaxoSmithKline Plc
  • Hologic Inc.
  • Illumina Inc.
  • Merck KGaA
  • Novartis AG
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Cancer Diagnostics Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by End-user
  • Exhibits35: Data Table on Comparison by End-user
  • Exhibits36: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Market opportunity by End-user ($ million)
  • Exhibits45: Data Table on Market opportunity by End-user ($ million)
  • Exhibits46: Chart on Type - Market share 2023-2028 (%)
  • Exhibits47: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits48: Chart on Comparison by Type
  • Exhibits49: Data Table on Comparison by Type
  • Exhibits50: Chart on IVD - Market size and forecast 2023-2028 ($ million)
  • Exhibits51: Data Table on IVD - Market size and forecast 2023-2028 ($ million)
  • Exhibits52: Chart on IVD - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on IVD - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Chart on Imaging - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Data Table on Imaging - Market size and forecast 2023-2028 ($ million)
  • Exhibits56: Chart on Imaging - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Data Table on Imaging - Year-over-year growth 2023-2028 (%)
  • Exhibits58: Chart on LDT - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on LDT - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on LDT - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on LDT - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Market opportunity by Type ($ million)
  • Exhibits63: Data Table on Market opportunity by Type ($ million)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on APAC - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on APAC - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on APAC - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on APAC - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Market opportunity By Geographical Landscape ($ million)
  • Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits107: Impact of drivers and challenges in 2023 and 2028
  • Exhibits108: Overview on criticality of inputs and factors of differentiation
  • Exhibits109: Overview on factors of disruption
  • Exhibits110: Impact of key risks on business
  • Exhibits111: Companies covered
  • Exhibits112: Matrix on companies position and classification
  • Exhibits113: Abbott Laboratories - Overview
  • Exhibits114: Abbott Laboratories - Business segments
  • Exhibits115: Abbott Laboratories - Key news
  • Exhibits116: Abbott Laboratories - Key offerings
  • Exhibits117: Abbott Laboratories - Segment focus
  • Exhibits118: Agilent Technologies Inc. - Overview
  • Exhibits119: Agilent Technologies Inc. - Business segments
  • Exhibits120: Agilent Technologies Inc. - Key news
  • Exhibits121: Agilent Technologies Inc. - Key offerings
  • Exhibits122: Agilent Technologies Inc. - Segment focus
  • Exhibits123: Becton Dickinson and Co. - Overview
  • Exhibits124: Becton Dickinson and Co. - Business segments
  • Exhibits125: Becton Dickinson and Co. - Key news
  • Exhibits126: Becton Dickinson and Co. - Key offerings
  • Exhibits127: Becton Dickinson and Co. - Segment focus
  • Exhibits128: Bristol Myers Squibb Co. - Overview
  • Exhibits129: Bristol Myers Squibb Co. - Product / Service
  • Exhibits130: Bristol Myers Squibb Co. - Key news
  • Exhibits131: Bristol Myers Squibb Co. - Key offerings
  • Exhibits132: Eli Lilly and Co. - Overview
  • Exhibits133: Eli Lilly and Co. - Product / Service
  • Exhibits134: Eli Lilly and Co. - Key news
  • Exhibits135: Eli Lilly and Co. - Key offerings
  • Exhibits136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits141: General Electric Co. - Overview
  • Exhibits142: General Electric Co. - Business segments
  • Exhibits143: General Electric Co. - Key news
  • Exhibits144: General Electric Co. - Key offerings
  • Exhibits145: General Electric Co. - Segment focus
  • Exhibits146: GlaxoSmithKline Plc - Overview
  • Exhibits147: GlaxoSmithKline Plc - Business segments
  • Exhibits148: GlaxoSmithKline Plc - Key news
  • Exhibits149: GlaxoSmithKline Plc - Key offerings
  • Exhibits150: GlaxoSmithKline Plc - Segment focus
  • Exhibits151: Hologic Inc. - Overview
  • Exhibits152: Hologic Inc. - Business segments
  • Exhibits153: Hologic Inc. - Key news
  • Exhibits154: Hologic Inc. - Key offerings
  • Exhibits155: Hologic Inc. - Segment focus
  • Exhibits156: Illumina Inc. - Overview
  • Exhibits157: Illumina Inc. - Business segments
  • Exhibits158: Illumina Inc. - Key news
  • Exhibits159: Illumina Inc. - Key offerings
  • Exhibits160: Illumina Inc. - Segment focus
  • Exhibits161: Merck KGaA - Overview
  • Exhibits162: Merck KGaA - Business segments
  • Exhibits163: Merck KGaA - Key news
  • Exhibits164: Merck KGaA - Key offerings
  • Exhibits165: Merck KGaA - Segment focus
  • Exhibits166: Novartis AG - Overview
  • Exhibits167: Novartis AG - Business segments
  • Exhibits168: Novartis AG - Key news
  • Exhibits169: Novartis AG - Key offerings
  • Exhibits170: Novartis AG - Segment focus
  • Exhibits171: QIAGEN NV - Overview
  • Exhibits172: QIAGEN NV - Product / Service
  • Exhibits173: QIAGEN NV - Key news
  • Exhibits174: QIAGEN NV - Key offerings
  • Exhibits175: Quest Diagnostics Inc. - Overview
  • Exhibits176: Quest Diagnostics Inc. - Business segments
  • Exhibits177: Quest Diagnostics Inc. - Key offerings
  • Exhibits178: Quest Diagnostics Inc. - Segment focus
  • Exhibits179: Thermo Fisher Scientific Inc. - Overview
  • Exhibits180: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits181: Thermo Fisher Scientific Inc. - Key news
  • Exhibits182: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits183: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits184: Inclusions checklist
  • Exhibits185: Exclusions checklist
  • Exhibits186: Currency conversion rates for US$
  • Exhibits187: Research methodology
  • Exhibits188: Information sources
  • Exhibits189: Data validation
  • Exhibits190: Validation techniques employed for market sizing
  • Exhibits191: Data synthesis
  • Exhibits192: 360 degree market analysis
  • Exhibits193: List of abbreviations
目次
Product Code: IRTNTR75667

The cancer diagnostics market is forecasted to grow by USD 17744.5 mn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the cancer diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, demand for personalized medicines, and need for cost-cutting in drug discovery and development.

Technavio's cancer diagnostics market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202411.73%
CAGR13.64%
Incremental Value$17744.5mn

By End-user

  • Hospitals and clinics
  • Diagnostic laboratories

By Type

  • IVD
  • Imaging
  • LDT

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • Rest of World (ROW)

This study identifies the increase in r and d and advances in technology as one of the prime reasons driving the cancer diagnostics market growth during the next few years. Also, adoption of various strategies like licensing agreements and commercializing products and vendors focusing on emerging countries with large populations to expand their presence will lead to sizable demand in the market.

The report on the cancer diagnostics market covers the following areas:

  • Cancer diagnostics market sizing
  • Cancer diagnostics market forecast
  • Cancer diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CANCER diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Astellas Pharma Inc., Becton Dickinson and Co., bioMerieux SA, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., General Electric Co., GlaxoSmithKline PLC, Hologic Inc., Illumina Inc., Merck KGaA, Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.. Also, the CANCER diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Cancer Diagnostics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Cancer Diagnostics Market 2018 - 2022 ($ million)
  • 4.2 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 6.3 Hospitals and clinics - Market size and forecast 2023-2028
    • Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • 6.4 Diagnostic laboratories - Market size and forecast 2023-2028
    • Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
    • Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
    • Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
    • Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 7.3 IVD - Market size and forecast 2023-2028
    • Chart on IVD - Market size and forecast 2023-2028 ($ million)
    • Data Table on IVD - Market size and forecast 2023-2028 ($ million)
    • Chart on IVD - Year-over-year growth 2023-2028 (%)
    • Data Table on IVD - Year-over-year growth 2023-2028 (%)
  • 7.4 Imaging - Market size and forecast 2023-2028
    • Chart on Imaging - Market size and forecast 2023-2028 ($ million)
    • Data Table on Imaging - Market size and forecast 2023-2028 ($ million)
    • Chart on Imaging - Year-over-year growth 2023-2028 (%)
    • Data Table on Imaging - Year-over-year growth 2023-2028 (%)
  • 7.5 LDT - Market size and forecast 2023-2028
    • Chart on LDT - Market size and forecast 2023-2028 ($ million)
    • Data Table on LDT - Market size and forecast 2023-2028 ($ million)
    • Chart on LDT - Year-over-year growth 2023-2028 (%)
    • Data Table on LDT - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 APAC - Market size and forecast 2023-2028
    • Chart on APAC - Market size and forecast 2023-2028 ($ million)
    • Data Table on APAC - Market size and forecast 2023-2028 ($ million)
    • Chart on APAC - Year-over-year growth 2023-2028 (%)
    • Data Table on APAC - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
  • 12.4 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
  • 12.5 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
  • 12.6 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 12.7 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 12.8 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 12.9 General Electric Co.
    • General Electric Co. - Overview
    • General Electric Co. - Business segments
    • General Electric Co. - Key news
    • General Electric Co. - Key offerings
    • General Electric Co. - Segment focus
  • 12.10 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
  • 12.11 Hologic Inc.
    • Hologic Inc. - Overview
    • Hologic Inc. - Business segments
    • Hologic Inc. - Key news
    • Hologic Inc. - Key offerings
    • Hologic Inc. - Segment focus
  • 12.12 Illumina Inc.
    • Illumina Inc. - Overview
    • Illumina Inc. - Business segments
    • Illumina Inc. - Key news
    • Illumina Inc. - Key offerings
    • Illumina Inc. - Segment focus
  • 12.13 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
  • 12.14 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 12.15 QIAGEN NV
    • QIAGEN NV - Overview
    • QIAGEN NV - Product / Service
    • QIAGEN NV - Key news
    • QIAGEN NV - Key offerings
  • 12.16 Quest Diagnostics Inc.
    • Quest Diagnostics Inc. - Overview
    • Quest Diagnostics Inc. - Business segments
    • Quest Diagnostics Inc. - Key offerings
    • Quest Diagnostics Inc. - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations